Sustained Acoustic Medicine Device sam® Offers an Alternative Solution to Pain Medication and Surgery

RAYUS Radiology Quality Institute Distinguished Nationally by Centers for Medicare & Medicaid

Quality Institute Again Earns Certification as Provider-Led Entity for Advanced Diagnostic Imaging Guidance to Clinicians.

LX1550 Multiparameter Remote Monitoring Platform Receives FDA 510 (k) Approval: Reports LifeSignals

Further validation of ability to deliver continuous remote patient vital signs monitoring within both hospital and home settings.

U.S. News & World Report Names Tampa General Hospital as Best in Tampa Bay

This is the sixth consecutive year that Tampa General has been named by U.S. News & World Report as Tampa Bay's top hospital.

JUNE 9, 2020

Sustained acoustic medicine device (sam®) from ZetrOZ Systems offers physicians and orthopedic surgeons an alternative solution to pain medication and surgery for their patients.

Medical providers can prescribe sam®, the only FDA-cleared long-duration ultrasound device, for prescription home-use to treat arthritis and soft tissue injuries.

sam® is a non-invasive prescription medical device that is applied over the target injury and delivers a localized treatment. The device is an excellent option for avoiding medication and delaying surgery, as well as improving postoperative healing and surgical outcomes. sam® is especially beneficial for patients who struggle with poor healing capability.

In addition to accelerating and improving the healing process, sam® is also a very effective treatment for pain arising from conditions such as arthritis, back spasms, disk herniation and tendonitis.

Sixty million people suffer from arthritis and 50 million people struggle with back pain in the United States alone. The leadership team at ZetrOZ Systems set a goal to help 100 million patients who are in pain or facing surgery. sam® does not block or mask pain. The device treats the damaged tissue and inflammatory response that causes it, getting to the root of the problem. ZetrOZ Systems believes that not all patients require surgery or medication.

“We want physicians and orthopedic surgeons to know they are not limited in the options they can offer patients. sam® gives them a viable, convenient alternative to prescribing drugs or putting patients under the knife,” said Dr. George Lewis, chief executive officer of ZetrOZ Systems.

While sam® is technologically sophisticated, it is also easy to use and apply, making it the perfect choice for home application by patients. The solution is convenient, as patients can engage in most activities while wearing it. sam® ships directly to the patient’s home, conserving clinic time and requiring little followup from medical providers.

Medical providers can prescribe sam® using a simple Rx form available at Patients typically undergo treatment for eight to 10 weeks. Each treatment includes the sam® device and five to eight packs of ultrasound coupling patches. Those with chronic arthritis pain will continue to use the device beyond 10 weeks to maintain their condition.



Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.